PATENT CLAIM ANALYSIS

Application Number: 16253431
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-07
Patent Classification: ["514", "419000"]

Abstract:
Compositions of indoleamine 2,3-dioxygenase (“IDO”) inhibitors and methods of use thereof are provided. The disclosed compositions may be used to inhibit or reduce kynurenine production in the blood, treat or prevent muscle loss, increase or maintain muscle mass, muscle strength and/or muscle function, and treat or prevent sarcopenia.

Claim (Index 4):
The method of  claim 1 , wherein the at least one IDO inhibitor is administered to the subject in an effective amount of about 200 to about 2500 mg/kg body weight.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 99.0
- Lexical Diversity: 1.31818
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10551151', '12810123', '14783426', '13186848', '10550444']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.757264211883288
- 35 USC 102 Novelty (BERT): 0.5102823273525091
- Combined Prediction Score: 0.7325660234302102
- Mean Citation Score: 209.365232
- Max Citation Score: 223.33194
- Similarity Product: 135.03698322882772

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test